search
Alzheimer's disease
Trends
- 1Alzheimer's disease increasingly seen as a treatable condition, study finds●Alzheimer's disease starting to be considered a treatable condition – study
A new study suggests Alzheimer's disease is beginning to be regarded as a treatable condition rather than an inevitably progressive, untreatable illness. The shift reflects growing confidence in emerging therapies that can modify the disease's course. The finding has drawn attention among health researchers and the public, with many discussing what it could mean for future diagnosis, treatment access, and the outlook for patients and families.
- 2Glucosamine linked to faster Alzheimer's progression, study suggests●Glucosamine, a popular joint supplement, linked to faster Alzheimer’s progression | ScienceDaily https://www. sciencedai
A widely used joint supplement, glucosamine, has been linked to faster progression of Alzheimer's disease, according to new research reported by ScienceDaily. The finding is drawing attention because millions of people take glucosamine for joint pain, believing it to be safe. Details of the study's methods and how strong the link is were not included in the available coverage.
- 3Blocking immune cells' entry into brain limits neurodegeneration▼Blocking immune cells’ path into brain limits neurodegeneration
Researchers at Washington University School of Medicine report that blocking the route immune cells use to enter the brain reduces neurodegeneration. The findings suggest that targeting immune cell trafficking could offer a new approach to slowing diseases such as Alzheimer's and other neurodegenerative conditions, though the work remains at the research stage.
- 4Wisconsin medical school wins grant to study Alzheimer's environmental links▼School of Medicine and Public Health receives grant to investigate links between Alzheimer’s environmental exposures
The University of Wisconsin School of Medicine and Public Health has received a grant to investigate possible links between environmental exposures and Alzheimer's disease. The funding will support research into how factors in the environment may contribute to the development of the neurodegenerative condition, an area of growing interest to scientists studying dementia risk.